Records 1 - 4
| EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.
International journal of clinical oncology 2021 Jul .
Wang Jia, Zhong Yanlin, Meng Guix
| Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.
Seminars in liver disease 2019 Mar .
Fujiwara Naoto, Hoshida Yuj
| Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Genetic testing and molecular biomarkers 2012 Sep 16 (9): 1086-91.
Yang Zhiping, Wu Qiong, Shi Yongquan, Nie Yongzhan, Wu Kaichun, Fan Daimi
| Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
European journal of gastroenterology & hepatology 2012 Apr 24 (4): 458-63.
Abbas Emad, Shaker Olfat, Abd El Aziz Ghada, Ramadan Huda, Esmat Gam